Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan 20;2(1):68.
doi: 10.1186/1757-1626-2-68.

Rupture and intra-peritoneal bleeding of a hepatocellular carcinoma after a transarterial chemoembolization procedure: a case report

Artan Reso  1 , Chad G Ball, Francis R Sutherland, Oliver Bathe, Elijah Dixon
Affiliations

Rupture and intra-peritoneal bleeding of a hepatocellular carcinoma after a transarterial chemoembolization procedure: a case report

Artan Reso et al. Cases J. .

Abstract

Background: Transarterial chemoembolization (TACE) is a well accepted treatment for inoperable hepatocellular carcinoma (HCC). While minor complications involve 10% of all patients, severe complications are rare.

Case presentation: We describe a case of a 90-year-old male with a large, superficial HCC who underwent TACE. He had a significant intraperitoneal bleed secondary to tumor rupture immediately following the procedure.

Conclusion: Tumor size and superficial location must be considered risk factors for tumor rupture and related complications.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Computed tomographic scan of ruptured hepatocellular carcinoma post-TACE.
Figure 2
Figure 2
Computed tomographic scan of ruptured hepatocellular carcinoma with associated hemorrhage immediately post-TACE.
See this image and copyright information in PMC

References

    1. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 2003;37:429–42. doi: 10.1053/jhep.2003.50047. - DOI - PubMed
    1. Rose MD, Chapman WC, Brokenbrough AT, Wright JK, Rose AT, Meranze S, Mazer M, Blair T, Blanke CD, Debelak JP, Wright-Pinson C. Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg. 1999;177:405–10. doi: 10.1016/S0002-9610(99)00069-0. - DOI - PubMed
    1. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. NEJM. 1995;332:1256–61. doi: 10.1056/NEJM199505113321903. - DOI - PubMed
    1. Kiely JM, Rilling WS, Touzios JG, Hieb RA, Franco J, Saeian K, Quebbeman EJ, Pitt HA. Chemoembolization in patients at high risk: results and complications. J Vasc Inter Rad. 2006;17:47–53. - PubMed
    1. Chan AO, Yuen MF, Hui CK, Tso WK, Lai CL. A prospective study regarding the complications of transcatheter chemoembolization in patients with hepatocellular carcinoma. Cancer. 2002;94:1747–52. doi: 10.1002/cncr.10407. - DOI - PubMed

LinkOut - more resources